High-Dose Versus Standard-Dose Influenza Vaccine in Heart Failure: A Prespecified Analysis of the DANFLU-2 Trial
Year: 2025
Type: article
Source: Circulation Heart Failure
Authors: Kristoffer Grundtvig Skaarup, Niklas Dyrby Johansen, Daniel Modin, Matthew M. Loiacono, Rebecca C. Harris, Marine Dufournet, Carsten Schade Larsen, Lykke Larsen, Lothar Wiese, Michael Dalager-Pedersen, Brian L. Claggett, Katja Vu Bartholdy, Katrine Feldballe Bernholm, Julie Inge-Marie Helene Borchsenius, Filip Soeskov Davidovski, Lise Witten Davodian, Maria Dons, Lisa Steen Duus, Caroline Espersen, Frederik Holme Fussing, Anne Marie Reimer Jensen, Nino Emanuel Landler, Adam Cadovius Femerling Langhoff, Mats C. H. Lassen, Anne Bjerg Nielsen, Camilla Ikast Ottosen, Morten Sengeløv, Scott D. Solomon, Martin J. Landray, Gunnar H. Gislason, Lars Køber, Pradeesh Sivapalan, Cyril Jean-Marie Martel, Jens Ulrik Stæhr Jensen, Alexandre Mebazaa, Tor Biering-Sørensen
Institutions: University of Copenhagen, Copenhagen University Hospital, Gentofte Hospital, University of Delaware, Sanofi (France), Aarhus University Hospital, Odense University Hospital, Roskilde Sygehus, Zealand University Hospital, Aalborg University Hospital, Aalborg University, Brigham and Women's Hospital, Harvard University, University of Oxford, University of Southern Denmark, Hjerteforeningen, Rigshospitalet, Statens Serum Institut, Inserm, Université Paris Cité, Assistance Publique – Hôpitaux de Paris, Hôpital Lariboisière, Hôpital Saint-Louis, Marqueurs cardiovasculaires en situation de stress, Steno Diabetes Center Copenhagen
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Danish Cardiovascular Academy
Award: G5290329898
OpenAlex ID: W4413845566